MedTrace Logo

Hoat Huyet Nhat Nhat Versus Tanakan for Treatment of Symptoms Related to the Insufficient Blood Supply to the Brain

NCT03216681 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 750

Last updated 2018-10-23

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness of Hoat Huyet Nhat Nhat on the reduction of common symptoms related to the insufficient blood supply to the brain such as headache, vertigo, dizziness, sleep disorders and forgetfulness; compared with Gingko Biloba Egb761 (Tanakan) after 45 days of treatment

Conditions

  • Insufficient Blood Supply to the Brain

Interventions

DRUG

Hoat Huyet Nhat Nhat

Administered orally twice a day, 2 tablets each time, for 45 days.

DRUG

Tanakan 40mg

Administered orally three times a day, 1 tablet each time, for 45 days.

Sponsors & Collaborators

  • Nhat Nhat Pharmaceutical Company

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2018-04-01
Completion
2018-04-30

Countries

  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03216681 on ClinicalTrials.gov